The authors found no effect on primary tumor growth or persistent virus infection, and only reported an increased frequency of tumor-free mice with a CD8+ T cell-specific Nrp-1 ablation compared to wild-type mice when secondary tumors were re-transplanted or upon re-infection, respectively [17, 18]. This evidence concerns the gene NRP1 and viral infectious disease.